Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

31. Januar 2011 12:11 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Achieves Ariston Merger Milestone

NEW YORK, Jan. 31, 2011 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced today that the company's Board of Directors has decided to continue development of AST-915, an orally...
10. Januar 2011 07:35 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Announces Entry Into Settlement and Release Agreement With Nordic Biotech

NEW YORK, Jan. 10, 2011 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced that on January 4, 2011, the company entered into a settlement and release agreement with Nordic...
16. Dezember 2010 07:49 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Announces Preliminary Phase 1/2 Results for AST-915 in Essential Tremor

NEW YORK, Dec. 16, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced preliminary results today from a Phase 1/2 study of AST-915 for the treatment of essential tremor....
08. November 2010 07:39 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Awarded $245K Grant Under the U.S. Qualified Therapeutic Discovery Project Credit Program

NEW YORK, Nov. 8, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic...
11. Oktober 2010 08:35 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals to Present at Precision IR Biotech, Healthcare & Pharmaceutical Virtual Conference

NEW YORK, Oct. 11, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) is scheduled to present at the Precision IR Biotech, Healthcare & Pharmaceutical Virtual Conference at...
14. April 2010 07:30 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Announces Private Placement Final Close at $3.0 Million

NEW YORK, April 14, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today announced the final close of its private placement in which it sold approximately 121 units, including...
12. März 2010 07:35 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Completes Merger Transaction With Ariston Pharmaceuticals

NEW YORK, March 12, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today announced it has entered into a definitive agreement and plan of merger and completed the merger...
04. März 2010 07:35 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Completes $2.5 Million Financing

NEW YORK, March 4, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today announced the private placement of $2,547,500 of its common stock and warrants to accredited...
18. Juni 2009 08:51 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Provides Corporate Update on Hedrin and Management Restructuring

NEW YORK, June 18, 2009 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today provided an update on its ongoing development programs. The Company also announced it has initiated a...
25. November 2008 08:11 ET | Quelle: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Completes $1 Million Financing

NEW YORK, Nov. 25, 2008 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today announced that it has completed the first closing of a private placement of secured debt and warrants to...

Vorherige Seite